Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock, par value $0.001 per share · CUSIP: 19459J104
Event date: 2025-09-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Renaissance Technologies LLC
Shares: 1,599,189 · Class: 5.06%
- Renaissance Technologies Holdings Corporation
Shares: 1,599,189 · Class: 5.06%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-25-000067
- Form type
- SCHEDULE 13G
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Nov 13, 2025
- Reporting period
- Sep 08, 2025
- Description
- Schedule 13G beneficial ownership